miRNA gene miRNA_log2FC miRNA_pvalue gene_log2FC gene_pvalue interactions correlation_beta correlation_pvalue PMID evidence outcome cancer hsa-miR-26a-5p ABCB9 -0.126411409001078 0.440028840408711 1.1211555252781 3.56430803400055e-08 miRNAWalker2_validate -0.323179164736964 2.41625989316895e-08 NA NA NA hsa-miR-26a-5p ACOT11 -0.126411409001078 0.440028840408711 1.18206936219683 1.85135072707042e-06 mirMAP -0.176916830736739 0.0130516339545499 NA NA NA hsa-miR-26a-5p ACTR3B -0.126411409001078 0.440028840408711 0.775489844816537 1.4103336486953e-06 miRNATAP -0.226899144841221 6.95067727988656e-07 NA NA NA hsa-miR-26a-5p ADAM12 -0.126411409001078 0.440028840408711 2.40624900645293 4.34494698353113e-09 mirMAP;miRNATAP -0.505768357416581 1.78713133438295e-05 NA NA NA hsa-miR-26a-5p ADM -0.126411409001078 0.440028840408711 -0.334920125742898 0.318812524968426 miRNAWalker2_validate;MirTarget;miRNATAP -0.356677800138835 0.000177384744692537 NA NA NA hsa-miR-26a-5p AKIRIN1 -0.126411409001078 0.440028840408711 -0.00600804332807403 0.955751507016914 miRNATAP -0.121918241297574 6.25612617773215e-05 NA NA NA hsa-miR-26a-5p ANKIB1 -0.126411409001078 0.440028840408711 0.472588710913856 7.2680592875853e-05 miRNATAP -0.142383879133015 2.51511966406491e-05 NA NA NA hsa-miR-26a-5p ANKRD52 -0.126411409001078 0.440028840408711 0.435644365596915 0.00335859064191175 mirMAP;miRNATAP -0.188060352525494 7.53466475670721e-06 NA NA NA hsa-miR-26a-5p ARL6IP6 -0.126411409001078 0.440028840408711 0.137398743924794 0.360453921695339 miRNATAP -0.190938485543918 6.35760394215147e-06 NA NA NA hsa-miR-26a-5p ATAD2 -0.126411409001078 0.440028840408711 1.58072414872602 1.32398935308252e-11 MirTarget -0.405009482936048 1.40965651167476e-09 NA NA NA hsa-miR-26a-5p ATAD2B -0.126411409001078 0.440028840408711 0.614158967546123 3.75199871605925e-07 MirTarget;miRNATAP -0.10529706341534 0.00236498430296846 NA NA NA hsa-miR-26a-5p AURKAIP1 -0.126411409001078 0.440028840408711 0.626086994795953 4.0224518469533e-05 miRNAWalker2_validate -0.162213789289755 0.000188790125941259 NA NA NA hsa-miR-26a-5p AVL9 -0.126411409001078 0.440028840408711 0.938497561012414 5.82058595143881e-09 mirMAP -0.212236118444481 4.32907951186505e-06 NA NA NA hsa-miR-26a-5p B3GNT5 -0.126411409001078 0.440028840408711 -0.325981838743923 0.143739702510876 MirTarget -0.235369383744595 0.000192958067980489 NA NA NA hsa-miR-26a-5p BARD1 -0.126411409001078 0.440028840408711 0.839638040780384 0.000347649752269475 MirTarget -0.251351458544639 0.00016979163199991 NA NA NA hsa-miR-26a-5p BRWD3 -0.126411409001078 0.440028840408711 0.679124124672604 0.000349066320112974 mirMAP -0.149507199408395 0.00584190537993819 NA NA NA hsa-miR-26a-5p C16orf87 -0.126411409001078 0.440028840408711 0.573199140734654 6.84303436430621e-06 mirMAP -0.117406653170428 0.00125689321445631 NA NA NA hsa-miR-26a-5p C20orf24 -0.126411409001078 0.440028840408711 1.14265959396339 2.64828141842954e-10 miRNATAP -0.217323050480656 3.04526676046712e-05 NA NA NA hsa-miR-26a-5p CARM1 -0.126411409001078 0.440028840408711 0.460820313098173 6.54223053882851e-06 miRNATAP -0.156954195976941 5.25802940590747e-08 NA NA NA hsa-miR-26a-5p CCDC43 -0.126411409001078 0.440028840408711 0.574691771320647 1.46567228734746e-07 miRNAWalker2_validate -0.13405891053989 1.70324503065133e-05 NA NA NA hsa-miR-26a-5p CCNE1 -0.126411409001078 0.440028840408711 2.99717740665025 1.61069658019784e-19 miRNAWalker2_validate;miRTarBase;miRNATAP -0.695101497950461 4.5037170303388e-13 22094936 Cell cycle regulation and CCNE1 and CDC2 were the only significant overlapping pathway and genes differentially expressed between tumors with high and low levels of miR-26a and EZH2 respectively; Low mRNA levels of EZH2 CCNE1 and CDC2 and high levels of miR-26a are associated with favorable outcome on tamoxifen breast cancer hsa-miR-26a-5p CCNE2 -0.126411409001078 0.440028840408711 2.14869777933212 3.82193505863706e-13 miRNAWalker2_validate;miRTarBase;miRNATAP -0.509665959363437 2.11729025570925e-09 24116110;21901171 The loss of miR 26a mediated post transcriptional regulation of cyclin E2 in pancreatic cancer cell proliferation and decreased patient survival; The in vitro and in vivo assays showed that overexpression of miR-26a resulted in cell cycle arrest inhibited cell proliferation and decreased tumor growth which was associated with cyclin E2 downregulation;We also show that enforced expression of miR-26a in AML cells is able to inhibit cell cycle progression by downregulating cyclin E2 expression poor survival;progression pancreatic cancer;acute myeloid leukemia hsa-miR-26a-5p CCNJ -0.126411409001078 0.440028840408711 0.51073520104177 0.000360239843570767 miRNATAP -0.117571525298324 0.00396506269298705 NA NA NA hsa-miR-26a-5p CDC6 -0.126411409001078 0.440028840408711 3.07280830186032 2.61005341863179e-21 miRNAWalker2_validate -0.731323800617234 6.56506901225912e-15 25100863;27158389 Here it is demonstrated that miR26a and miR26b inhibit replication licensing and the proliferation migration and invasion of lung cancer cells by targeting CDC6; The current study suggests that miR26a miR26b and CDC6 and factors regulating their expression represent potential cancer diagnostic and prognostic markers as well as anticancer targets;miR 26a inhibits the proliferation of ovarian cancer cells via regulating CDC6 expression; Bioinformatics analysis revealed Cdc6 was a target gene of miR-26a; dual-luciferase assay and validation assay showed miR-26a could act on the 3'UTR of Cdc6 to regulate Cdc6 expression; These findings suggest that miR-26a may act on the 3'UTR of Cdc6 to regulate Cdc6 expression which then inhibit the proliferation of ovarian cancer cells and induce their apoptosis ; lung cancer;ovarian cancer hsa-miR-26a-5p CDH2 -0.126411409001078 0.440028840408711 0.208460444138559 0.682352061982617 miRNATAP -0.494609072495664 0.000614175362243147 NA NA NA hsa-miR-26a-5p CDK2AP1 -0.126411409001078 0.440028840408711 0.323823706547641 0.0136596194572327 MirTarget;miRNATAP -0.114716183461438 0.00207459362016803 NA NA NA hsa-miR-26a-5p CDK8 -0.126411409001078 0.440028840408711 0.300242294414736 0.0307119827502737 miRNAWalker2_validate -0.231492309931046 2.58371874983049e-09 NA NA NA hsa-miR-26a-5p CDR2L -0.126411409001078 0.440028840408711 0.25998843402788 0.217682696244846 miRNATAP -0.236775486116786 7.16625844686654e-05 NA NA NA hsa-miR-26a-5p CEBPG -0.126411409001078 0.440028840408711 0.0517536919914541 0.715693313043818 miRNATAP -0.1069950131803 0.00786869120052156 NA NA NA hsa-miR-26a-5p CENPP -0.126411409001078 0.440028840408711 0.513704105103643 0.00812754799461501 mirMAP -0.201012559355155 0.000263754266262076 NA NA NA hsa-miR-26a-5p CHAC1 -0.126411409001078 0.440028840408711 0.96062388185063 0.00030561379790455 MirTarget;miRNATAP -0.226033326484843 0.00294240965000026 NA NA NA hsa-miR-26a-5p CHORDC1 -0.126411409001078 0.440028840408711 0.883294935601413 9.52590828255541e-09 MirTarget -0.251280082611059 9.5758771687487e-09 NA NA NA hsa-miR-26a-5p CLTC -0.126411409001078 0.440028840408711 0.437713347422649 8.69514117497297e-05 miRNATAP -0.12528537755853 7.54422056865606e-05 NA NA NA hsa-miR-26a-5p CNTD2 -0.126411409001078 0.440028840408711 3.51171210672883 6.8388880918194e-12 miRNAWalker2_validate -0.461999866352578 0.00191935232302858 NA NA NA hsa-miR-26a-5p COASY -0.126411409001078 0.440028840408711 0.763543836125371 1.40630384756548e-12 miRNAWalker2_validate -0.210321679189172 6.61165786086202e-12 NA NA NA hsa-miR-26a-5p COL11A1 -0.126411409001078 0.440028840408711 5.23228286350859 2.85537482242574e-12 miRNATAP -0.978362423046049 6.48079472118884e-06 NA NA NA hsa-miR-26a-5p COL12A1 -0.126411409001078 0.440028840408711 -0.849027180514303 0.034965601861609 miRNATAP -0.354982549299829 0.00193539103088857 NA NA NA hsa-miR-26a-5p COL1A2 -0.126411409001078 0.440028840408711 0.876118168211992 0.00368711342738012 MirTarget;miRNATAP -0.253542314755959 0.00320050316582886 NA NA NA hsa-miR-26a-5p COL5A1 -0.126411409001078 0.440028840408711 1.56547504280567 2.15706253605725e-07 miRNATAP -0.287347840568329 0.000932321553623759 NA NA NA hsa-miR-26a-5p COPS7B -0.126411409001078 0.440028840408711 0.707011523635339 9.81691463940276e-13 miRNATAP -0.169195099399196 2.31165603311389e-09 NA NA NA hsa-miR-26a-5p CPD -0.126411409001078 0.440028840408711 0.911876479581357 9.08443596366211e-05 MirTarget;mirMAP -0.227259326048398 0.000634915073665941 NA NA NA hsa-miR-26a-5p DCUN1D1 -0.126411409001078 0.440028840408711 0.144235891193565 0.301323427210419 mirMAP -0.109425023680304 0.00564960539582928 NA NA NA hsa-miR-26a-5p DEPDC1 -0.126411409001078 0.440028840408711 3.4453193569446 8.88810549846053e-21 MirTarget -0.719975750834529 2.07228860869089e-11 NA NA NA hsa-miR-26a-5p DEPDC1B -0.126411409001078 0.440028840408711 3.46407492638038 1.28193624486327e-22 MirTarget;miRNATAP -0.608347054819373 5.33025085458248e-09 NA NA NA hsa-miR-26a-5p DGCR14 -0.126411409001078 0.440028840408711 0.169538861688061 0.145952859916462 mirMAP;miRNATAP -0.133897891061098 4.58367535459861e-05 NA NA NA hsa-miR-26a-5p DHX15 -0.126411409001078 0.440028840408711 0.34892171542846 0.000469017671369664 miRNAWalker2_validate -0.105633702891802 0.000184182632907127 NA NA NA hsa-miR-26a-5p DLG5 -0.126411409001078 0.440028840408711 1.13470194530037 1.25261259893009e-11 MirTarget;miRNATAP -0.25506947953992 1.16138179012671e-07 NA NA NA hsa-miR-26a-5p DNAJC10 -0.126411409001078 0.440028840408711 0.796767822766086 8.14292717637844e-08 mirMAP -0.114331872525138 0.00747754538469392 NA NA NA hsa-miR-26a-5p DNMT1 -0.126411409001078 0.440028840408711 0.717163442274989 1.44212780835058e-06 miRNAWalker2_validate -0.267777758129292 1.71989249624568e-10 NA NA NA hsa-miR-26a-5p E2F2 -0.126411409001078 0.440028840408711 2.22473169258522 4.76223979917143e-17 miRNATAP -0.50169847179153 5.96567290285655e-11 26458859 MiR 26a enhances the sensitivity of gastric cancer cells to cisplatin by targeting NRAS and E2F2; Our results suggest that miR-26a can improve the sensitivity of GC cells to cisplatin-based chemotherapies through targeting NRAS and E2F2 and provide the first evidence of the potential utility of miR-26a as a sensitizer in chemotherapy for GC gastric cancer hsa-miR-26a-5p E2F7 -0.126411409001078 0.440028840408711 2.39526374034582 5.46012949053379e-12 miRNAWalker2_validate;miRNATAP -0.461308832910507 4.40880272403452e-06 23096114 Here we identify E2F7 as a novel target of miR-26a; Thus these findings indicate that the newly identified miR-26a target E2F7 might have an important role in monocytic differentiation and leukemogenesis differentiation acute myeloid leukemia hsa-miR-26a-5p EIF2AK2 -0.126411409001078 0.440028840408711 0.620787530289015 8.73480825216513e-05 mirMAP -0.140620319244894 0.00184853127994259 NA NA NA hsa-miR-26a-5p ELOVL6 -0.126411409001078 0.440028840408711 0.819759240003576 0.0278715609826653 miRNAWalker2_validate -0.261238676406014 0.0139338346770514 NA NA NA hsa-miR-26a-5p EP400 -0.126411409001078 0.440028840408711 0.145076802720138 0.272088257372572 MirTarget;miRNATAP -0.111253863931129 0.0029272318628394 NA NA NA hsa-miR-26a-5p EZH2 -0.126411409001078 0.440028840408711 2.63566539246403 3.78349576722754e-27 miRNAWalker2_validate;miRTarBase;MirTarget;miRNATAP -0.552405796444427 1.30452959392404e-14 20952513;23750239;25611389;24452597;26733151;21901171;25494962;27517917;22086681;27562865;22930729;22094936 Pathologically decreased miR 26a antagonizes apoptosis and facilitates carcinogenesis by targeting MTDH and EZH2 in breast cancer; Subsequently MTDH and EZH2 are identified as two direct targets of miR-26a and they are significantly upregulated in breast cancer; MCF7 xenografts with exogenous miR-26a show that a decrease in expression of both MTDH and EZH2 is accompanied by an increase in apoptosis; Our findings suggest that miR-26a functionally antagonizes human breast carcinogenesis by targeting MTDH and EZH2;MiR-26a has been reported as a tumor suppressor microRNA in breast cancer which is attributed mainly to targeting of MTDH and EZH2 however the expression profile and therapeutic potential of miR-26a is still unclear;Significant inverse correlation between EZH2 and hsa-miR-26a-5p R2=0.56 P=0.0001 and hsa-let-7b-5p R2=0.19 P=0.02 expression was observed in the same samples corroborating the belief of EZH2 being a bona fide target for these two miRNAs in CRC;Moreover EZH2 was upregulated and inversely correlated with miR-26a expression in the osteosarcoma tissues; Thus for the first time we provide convincing evidence that downregulation of miR-26a is associated with tumor aggressiveness and tumor metastasis and miR-26a inhibits cell migration and invasion by targeting the EZH2 gene in osteosarcoma;Through down-regulation of EZH2 expression and up-regulation of E-cadherin expression miR-26a inhibited the EMT process in vitro and in vivo; Luciferase reporter assay showed that miR-26a directly interacted with EZH2 messenger RNA mRNA; Furthermore the expression of miR-26a was positively correlated with E-cadherin expression and inversely correlated with EZH2 expression in human HCC tissue; miR-26a inhibited the EMT process in HCC by down-regulating EZH2 expression;Previously EZH2 was shown to be regulated by miR-26a at the translational levels in lymphomas;miR 26a promoted by interferon alpha inhibits hepatocellular carcinoma proliferation and migration by blocking EZH2; Here we report that the IFN-α-induced microRNA-26a miR-26a can inhibit HCC proliferation and invasion by suppressing enhancer of zeste homologue 2 EZH2 expression in tumor cells; It was shown that there was increased miR-26a accompanied with downregulated EZH2 expression in the HCC specimens and EZH2 mRNA levels were inversely correlated with miR-26a expression; In addition the miR-26a mimic transfection decreased the EZH2 expression level significantly in the transfected HepG2 cells and inhibited HepG2 cell proliferation and invasion effectively; Our results indicate that miR-26a exerts growth inhibition in HCC and that its inhibitory effect is mediated briefly by blocking EZH2 expression;miR-26a inhibition partly prevents the metformin viability effect and the PTEN and EZH2 expression reduction;We also found that reexpression of miR-26a by transfection led to decreased expression of EZH2 and EpCAM in pancreatic cancer cells;In the present study the influence of miR-26a and miR-138 on EZH2 and cellular function including the impact on the cell cycle regulating network was evaluated in PCa cells; The present findings suggest an anti-proliferative role for miR-26a and miR-138 in PCa by blocking the G1/S-phase transition independent of EZH2 but via a concerted inhibition of crucial cell cycle regulators;We propose the hypermethylation of miR-26a as an alternative pathway of ERG rearrangement-independent EZH2 activation;High miR 26a and low CDC2 levels associate with decreased EZH2 expression and with favorable outcome on tamoxifen in metastatic breast cancer; Main objective of the present study is to investigate miR-26a and miR-101 levels which both target EZH2 for their association with molecular pathways and with efficacy of tamoxifen as first-line monotherapy for metastatic breast cancer; Cell cycle regulation and CCNE1 and CDC2 were the only significant overlapping pathway and genes differentially expressed between tumors with high and low levels of miR-26a and EZH2 respectively; Cell cycle regulation is the only overlapping pathway linked to miR-26a and EZH2 levels; Low mRNA levels of EZH2 CCNE1 and CDC2 and high levels of miR-26a are associated with favorable outcome on tamoxifen tumorigenesis;;;metastasis;cell migration;;;;;;;; breast cancer;breast cancer;colorectal cancer;sarcoma;liver cancer;acute myeloid leukemia;liver cancer;breast cancer;pancreatic cancer;prostate cancer;prostate cancer;breast cancer hsa-miR-26a-5p FAM136A -0.126411409001078 0.440028840408711 1.18430145873601 1.38323839129987e-21 MirTarget;miRNATAP -0.228137139151575 3.00906805332246e-10 NA NA NA hsa-miR-26a-5p FAM199X -0.126411409001078 0.440028840408711 0.788148993932119 9.46860038929325e-09 mirMAP -0.15014392043907 0.000139881508027499 NA NA NA hsa-miR-26a-5p FAM49B -0.126411409001078 0.440028840408711 0.404948409766247 0.00295807020255253 miRNATAP -0.118686393467281 0.00217769324851333 NA NA NA hsa-miR-26a-5p FAM98A -0.126411409001078 0.440028840408711 0.629938824895667 2.44364633573002e-10 MirTarget;miRNATAP -0.161758865160172 1.11358608305011e-08 NA NA NA hsa-miR-26a-5p FANCA -0.126411409001078 0.440028840408711 2.05908519185299 3.63337130144689e-20 miRNATAP -0.443565529024891 9.27604557620594e-12 NA NA NA hsa-miR-26a-5p FANCF -0.126411409001078 0.440028840408711 0.972071870685326 1.26490707730254e-16 MirTarget -0.112193845453226 0.00110420188734872 NA NA NA hsa-miR-26a-5p FASN -0.126411409001078 0.440028840408711 -0.686509530936284 0.00938573479012896 miRNAWalker2_validate -0.271955023238144 0.000291875720492757 NA NA NA hsa-miR-26a-5p FBXL19 -0.126411409001078 0.440028840408711 1.33107321421435 1.14940978087523e-14 miRNATAP -0.413507569237977 2.24025135867412e-17 NA NA NA hsa-miR-26a-5p FBXO32 -0.126411409001078 0.440028840408711 1.91595142423657 1.46314381556444e-12 mirMAP -0.225339212902103 0.00428704111431432 NA NA NA hsa-miR-26a-5p FEN1 -0.126411409001078 0.440028840408711 1.39358950117114 1.13121829224272e-13 MirTarget -0.358820466989705 2.45897730549436e-11 NA NA NA hsa-miR-26a-5p FGD1 -0.126411409001078 0.440028840408711 0.40535990497792 0.08404343037993 MirTarget;miRNATAP -0.331762370178259 5.13971325423728e-07 NA NA NA hsa-miR-26a-5p FLVCR1 -0.126411409001078 0.440028840408711 1.36685243698232 5.19460627745174e-12 MirTarget;miRNATAP -0.171147420651995 0.00296252126880915 NA NA NA hsa-miR-26a-5p GDAP1 -0.126411409001078 0.440028840408711 0.104671665900572 0.63941670555552 miRNAWalker2_validate;miRTarBase -0.163969078141886 0.00974769414241604 NA NA NA hsa-miR-26a-5p GJC1 -0.126411409001078 0.440028840408711 -0.594913234242691 0.0159765868981794 mirMAP -0.16851671960439 0.0166383967354987 NA NA NA hsa-miR-26a-5p GMPS -0.126411409001078 0.440028840408711 0.624220828855719 4.24762356255573e-05 mirMAP -0.210967981478957 1.05464664176423e-06 NA NA NA hsa-miR-26a-5p GRB10 -0.126411409001078 0.440028840408711 0.160703976200381 0.476789963428872 MirTarget -0.16766365728747 0.00895381644285532 NA NA NA hsa-miR-26a-5p GTF3C2 -0.126411409001078 0.440028840408711 0.505525276593751 7.34679061990725e-08 miRNATAP -0.16895487897877 1.63676925653674e-10 NA NA NA hsa-miR-26a-5p HAPLN1 -0.126411409001078 0.440028840408711 -0.220005767993027 0.681505192142052 MirTarget;miRNATAP -0.446843929053845 0.00333109240261617 NA NA NA hsa-miR-26a-5p HIST1H4J -0.126411409001078 0.440028840408711 1.33388357394754 1.08775929211286e-06 miRNAWalker2_validate -0.293252888564174 0.000183765135433342 NA NA NA hsa-miR-26a-5p HIST2H2AA3 -0.126411409001078 0.440028840408711 1.74462251425235 3.33087016283113e-08 miRNAWalker2_validate -0.271988459861417 0.00283095413901629 NA NA NA hsa-miR-26a-5p HMGA1 -0.126411409001078 0.440028840408711 1.93147380299731 1.42272508188732e-14 miRNAWalker2_validate;miRTarBase;MirTarget;miRNATAP -0.441449732413678 1.06432655060421e-09 25455159;25755724;23796420;22245693 Prognostic value of miR 26a and HMGA1 in urothelial bladder cancer; MicroRNA-26a miR-26a functions as a tumor suppressor by regulating its direct target gene high mobility group AT-hook 1 HMGA1; This study was aimed to investigate the associations of differential expression of miR-26a and HMGA1 with tumor progression and prognosis in urothelial bladder cancer UBC patients; One hundred and twenty-six UBC patients were selected and quantitative real-time PCR was performed to detect the expression of miR-26a and HMGA1 mRNA in the respective tumors; Our data showed the decreased expression of miR-26a and the increased expression of HMGA1 mRNA in UBC tissues compared with corresponding non-cancerous tissues both P<0.001; Then the expression levels of miR-26a in UBC tissues were negatively correlated with those of HMGA1 mRNA significantly r=-0.72 P<0.001; In addition UBC patients with combined miR-26a downregulation and HMGA1 upregulation miR-26a-low/HMGA1-high more frequently had advanced pathological stage P<0.001 and high tumor grade P<0.001; Interaction between miR-26a and its target gene HMGA1 may contribute to the malignant progression of human UBC; Tumors with miR-26a downregulation in combination with high expression of HMGA1 showed a worse prognosis than the other tumors;To investigate the crucial role of miR-26a in breast cancer and to validate whether miR-26a could regulate proliferation of breast cancer cells by targeting high mobility group AT-hook 1 HMGA1; The luciferase activity was significantly decreased after co-transfection with psiCHECK-2/HMGA1 3'-UTR and miR-26a mimics in comparison with control cells and qRT-PCR and Western blotting analysis found that HMGA1 expression at the mRNA and protein levels decreased in the miR-26a mimic-treatment group relative to NC; MTT assay showed that down regulation of HMGA1 by siRNA could significantly enhance the tumor-suppressive effect of miR-26a P < 0.05; The results of the present study indicate that miR-26a may be associated with human breast carcinogenesis which inhibits tumor cell proliferation by targeting HMGA1;miR 26a inhibits proliferation and motility in bladder cancer by targeting HMGA1; High mobility group AT-hook 1 HMGA1 a gene that modulates cell cycle transition and cell motility was verified as a novel target of miR-26a in bladder cancer;HMGA1 was proved to be a target of miR-26a by Luciferase reporter assay Real-time PCR and Western-blotting; Furthermore we demonstrated that HMGA1 an oncogene is a direct target of miR-26a; Nude mice xenograft models confirmed that metformin up-regulated the level of miR-26a and surpressed the expression of HMGA1 in vivo progression;worse prognosis;staging;malignant trasformation;tumorigenesis;motility; bladder cancer;breast cancer;bladder cancer;pancreatic cancer hsa-miR-26a-5p HMGB3 -0.126411409001078 0.440028840408711 2.90718824931638 8.20634808663043e-18 mirMAP -0.286023198484331 0.00416603037086701 NA NA NA hsa-miR-26a-5p HOXD13 -0.126411409001078 0.440028840408711 1.140701910522 0.0715293093945188 miRNATAP -0.499424525135743 0.00556528201034062 NA NA NA hsa-miR-26a-5p HS6ST1 -0.126411409001078 0.440028840408711 0.0446015172756846 0.801401031688771 miRNATAP -0.101346211991845 0.0442495684944372 NA NA NA hsa-miR-26a-5p HSPA13 -0.126411409001078 0.440028840408711 0.0660461335018709 0.67190302740316 miRNATAP -0.113665809590577 0.0101538762634408 NA NA NA hsa-miR-26a-5p HSPA8 -0.126411409001078 0.440028840408711 0.0569055608302378 0.6886867098448 miRNAWalker2_validate -0.113550039485136 0.00475859102893472 NA NA NA hsa-miR-26a-5p HUWE1 -0.126411409001078 0.440028840408711 0.2428746589499 0.0715201235034078 miRNATAP -0.105208771815253 0.00591408547185826 NA NA NA hsa-miR-26a-5p ITGA5 -0.126411409001078 0.440028840408711 -1.01121491098415 8.84227998350758e-06 miRNATAP -0.204698760741648 0.00168812743238086 25537511 Furthermore we provide experimental evidence to confirm that ITGA5 is a bona fide target of miR-26a liver cancer hsa-miR-26a-5p ITSN1 -0.126411409001078 0.440028840408711 -0.279284867182052 0.035252782717714 mirMAP -0.103165886599219 0.00613131752939782 NA NA NA hsa-miR-26a-5p KCMF1 -0.126411409001078 0.440028840408711 0.270811481056203 0.00636064047805838 miRNATAP -0.111172601381373 7.18482522035248e-05 NA NA NA hsa-miR-26a-5p KCTD5 -0.126411409001078 0.440028840408711 0.55754924196518 3.19719885486173e-05 miRNAWalker2_validate -0.119446215353001 0.00179808612950997 NA NA NA hsa-miR-26a-5p KIAA1147 -0.126411409001078 0.440028840408711 -0.204176060599798 0.184061334514689 mirMAP -0.104564053708449 0.0165701698260284 NA NA NA hsa-miR-26a-5p KPNA1 -0.126411409001078 0.440028840408711 0.0774164708184992 0.4478025343801 mirMAP -0.116060254835345 5.15986030515885e-05 NA NA NA hsa-miR-26a-5p KPNA2 -0.126411409001078 0.440028840408711 1.69119087105328 2.91951617049277e-13 MirTarget -0.502612448017839 2.31791917806009e-14 NA NA NA hsa-miR-26a-5p LARP1 -0.126411409001078 0.440028840408711 0.422200044532952 0.00110425642523566 miRNATAP -0.145379446119467 7.37947755819252e-05 26063484 Gene expression data and in silico analysis showed that the gene encoding La-related protein 1 LARP1 was a putative candidate of miR-26a and miR-26b regulation; Moreover luciferase reporter assays revealed that LARP1 was a direct target of both miR-26a and miR-26b; Our present data suggested that loss of tumor-suppressive miR-26a and miR-26b enhanced cancer cell invasion in PCa through direct regulation of oncogenic LARP1 prostate cancer hsa-miR-26a-5p LINGO1 -0.126411409001078 0.440028840408711 1.63725568539424 5.0746214204727e-06 miRNATAP -0.212183053807923 0.0398922724633546 NA NA NA hsa-miR-26a-5p LPGAT1 -0.126411409001078 0.440028840408711 0.965572372904362 4.14640366517532e-10 mirMAP -0.112355191249808 0.0120299909910556 NA NA NA hsa-miR-26a-5p LSM12 -0.126411409001078 0.440028840408711 0.62699745664688 8.80047940200662e-09 MirTarget;miRNATAP -0.115556177038153 0.000217391358344482 NA NA NA hsa-miR-26a-5p MAEA -0.126411409001078 0.440028840408711 0.363400635651982 0.000350194508728585 MirTarget -0.118989162651096 3.49291100029036e-05 NA NA NA hsa-miR-26a-5p MAP2 -0.126411409001078 0.440028840408711 -1.20387553493088 0.000895067915840975 MirTarget;miRNATAP -0.204907283268036 0.048271677584232 NA NA NA hsa-miR-26a-5p MAP7 -0.126411409001078 0.440028840408711 0.444391918230147 0.0106684371761414 MirTarget -0.130232860404149 0.00856502366893378 NA NA NA hsa-miR-26a-5p MAPK6 -0.126411409001078 0.440028840408711 0.442185686434684 0.00511509129113629 MirTarget -0.227787183836652 3.08650143966832e-07 NA NA NA hsa-miR-26a-5p MEX3B -0.126411409001078 0.440028840408711 0.957582152806022 1.38244360621664e-06 miRNATAP -0.224071281353485 7.82565099895564e-05 NA NA NA hsa-miR-26a-5p MLEC -0.126411409001078 0.440028840408711 0.378188080636328 0.0154450070180976 miRNATAP -0.123365254586633 0.00545121723902273 NA NA NA hsa-miR-26a-5p MMP14 -0.126411409001078 0.440028840408711 0.853770939661442 0.000211702855196161 miRNATAP -0.236934517399567 0.000310393452321971 NA NA NA hsa-miR-26a-5p MRPL35 -0.126411409001078 0.440028840408711 0.421583682109827 2.25597572652792e-05 mirMAP -0.108511181575509 0.000121969474701477 NA NA NA hsa-miR-26a-5p MRPL51 -0.126411409001078 0.440028840408711 0.503084200308061 9.21441777441909e-05 miRNAWalker2_validate -0.1286292090456 0.00044355828462813 NA NA NA hsa-miR-26a-5p MSH6 -0.126411409001078 0.440028840408711 0.603431222186702 1.86969367235948e-05 miRNAWalker2_validate -0.207306504698793 2.05373907355778e-07 NA NA NA hsa-miR-26a-5p MTHFD2 -0.126411409001078 0.440028840408711 1.38116504109133 3.40087940122038e-10 mirMAP -0.352260101193581 2.18186944981716e-08 NA NA NA hsa-miR-26a-5p MTX2 -0.126411409001078 0.440028840408711 0.834593671147864 3.42210589957025e-13 MirTarget;miRNATAP -0.105427772550762 0.00155210814857024 NA NA NA hsa-miR-26a-5p NAA15 -0.126411409001078 0.440028840408711 0.434835391794936 0.000489315116278007 MirTarget;miRNATAP -0.164849784496571 2.917426745487e-06 NA NA NA hsa-miR-26a-5p NACC2 -0.126411409001078 0.440028840408711 -0.766517132485546 9.86214088829339e-05 mirMAP;miRNATAP -0.131084282621346 0.0200285209746585 NA NA NA hsa-miR-26a-5p NAMPT -0.126411409001078 0.440028840408711 0.025988903642669 0.921706421025021 miRNATAP -0.21066451907414 0.00500524701318241 NA NA NA hsa-miR-26a-5p NAV1 -0.126411409001078 0.440028840408711 0.643081042817989 0.00272015580998536 mirMAP -0.172284494894785 0.00484379182207737 NA NA NA hsa-miR-26a-5p NLK -0.126411409001078 0.440028840408711 0.200178958380761 0.0535794568700787 miRNATAP -0.110559225376151 0.000156249291102499 NA NA NA hsa-miR-26a-5p NPLOC4 -0.126411409001078 0.440028840408711 0.621972533624965 2.23854402271804e-08 mirMAP -0.185195841266854 4.16674329774429e-09 NA NA NA hsa-miR-26a-5p NT5DC3 -0.126411409001078 0.440028840408711 0.690836878870525 0.000252254955596184 mirMAP -0.239192618776333 7.99845754488593e-06 NA NA NA hsa-miR-26a-5p NUP153 -0.126411409001078 0.440028840408711 0.0503878867933567 0.695573741426605 miRNATAP -0.122803796394895 0.000735019121787557 NA NA NA hsa-miR-26a-5p NUP155 -0.126411409001078 0.440028840408711 1.05660120881283 9.40636592440548e-08 mirMAP -0.292885797124114 2.09743529804556e-07 NA NA NA hsa-miR-26a-5p NUP205 -0.126411409001078 0.440028840408711 0.476965923583248 0.000695207062231521 miRNAWalker2_validate -0.257124723612281 6.2830961092334e-11 NA NA NA hsa-miR-26a-5p OLA1 -0.126411409001078 0.440028840408711 0.820686645642415 4.84795948840091e-10 miRNAWalker2_validate -0.140728415915223 0.000211216696429182 NA NA NA hsa-miR-26a-5p OTUD6B -0.126411409001078 0.440028840408711 0.280332778435085 0.0746340465601679 MirTarget -0.161410023036055 0.000287292405623554 NA NA NA hsa-miR-26a-5p PAWR -0.126411409001078 0.440028840408711 0.414006493998714 0.00956669483547845 MirTarget;mirMAP -0.269369718234263 1.76756333392639e-09 NA NA NA hsa-miR-26a-5p PCCB -0.126411409001078 0.440028840408711 0.266396200473873 0.021572073948102 mirMAP -0.114400583329291 0.000485810415487742 NA NA NA hsa-miR-26a-5p PCYT1A -0.126411409001078 0.440028840408711 -0.130866451561566 0.283918253910384 miRNAWalker2_validate -0.12516216746517 0.000281967102042442 NA NA NA hsa-miR-26a-5p PGM2 -0.126411409001078 0.440028840408711 -0.0494374399802551 0.774993376849384 MirTarget -0.160342484183667 0.00105592196975355 NA NA NA hsa-miR-26a-5p PGM2L1 -0.126411409001078 0.440028840408711 1.69535158857047 3.32945698097982e-15 miRNATAP -0.22356231645409 0.000381845339706827 NA NA NA hsa-miR-26a-5p PHF6 -0.126411409001078 0.440028840408711 0.641040656384869 6.11918396852708e-07 MirTarget;mirMAP;miRNATAP -0.131156748117489 0.000360276001938116 NA NA NA hsa-miR-26a-5p PHTF2 -0.126411409001078 0.440028840408711 0.568974067702746 0.000118173985993022 MirTarget;miRNATAP -0.162164020216541 0.000114532036361555 NA NA NA hsa-miR-26a-5p PI15 -0.126411409001078 0.440028840408711 0.835096398752105 0.0420187389820186 mirMAP -0.268995078506631 0.0215700380455188 NA NA NA hsa-miR-26a-5p PITPNC1 -0.126411409001078 0.440028840408711 0.360691200119788 0.149452726061611 MirTarget;miRNATAP -0.260651942357379 0.000235829470817179 NA NA NA hsa-miR-26a-5p PLEKHH1 -0.126411409001078 0.440028840408711 0.346459699737567 0.361292700670392 miRNATAP -0.239325122077229 0.0266896270985941 NA NA NA hsa-miR-26a-5p PLOD2 -0.126411409001078 0.440028840408711 1.27626900643861 6.592887294488e-05 MirTarget;miRNATAP -0.468339724882361 2.40086489698333e-07 26983694;27310702 Thus our data showed that two genes promoting metastasis LOXL2 and PLOD2 were epigenetically regulated by tumor-suppressive microRNAs miR-26a and miR-26b providing important insights into the molecular mechanisms of RCC metastasis;The gene encoding procollagen-lysine 2-oxoglutarate 5-dioxygenase 2 PLOD2 a collagen crosslinking enzyme was directly regulated by miR-26a-5p and miR-26b-5p; PLOD2 which is associated with the stiffness of the extracellular matrix was directly regulated by miR-26a-5p and miR-26b-5p and may be a good prognostic marker in patients with BC metastasis; kidney renal cell cancer;bladder cancer hsa-miR-26a-5p POLR3G -0.126411409001078 0.440028840408711 0.675838969394989 0.00520811911898698 MirTarget -0.346579081022979 3.86358707943556e-07 NA NA NA hsa-miR-26a-5p POM121 -0.126411409001078 0.440028840408711 0.177261527843018 0.109545284975034 mirMAP -0.118767623169282 0.000143296550740942 NA NA NA hsa-miR-26a-5p PPIA -0.126411409001078 0.440028840408711 0.446598636191056 0.000591389275206593 miRNAWalker2_validate -0.119640307127027 0.00121184299515135 NA NA NA hsa-miR-26a-5p PPP1CC -0.126411409001078 0.440028840408711 0.14862984928136 0.172735526583351 miRNAWalker2_validate -0.103235841569694 0.000794412329745643 NA NA NA hsa-miR-26a-5p PTDSS1 -0.126411409001078 0.440028840408711 0.014323601906522 0.904640686008302 mirMAP -0.140974234552484 2.77743218630916e-05 NA NA NA hsa-miR-26a-5p PTTG1 -0.126411409001078 0.440028840408711 2.29967103891773 7.51122159159736e-16 miRNAWalker2_validate -0.404247341427357 1.14869729062631e-06 NA NA NA hsa-miR-26a-5p RAB3B -0.126411409001078 0.440028840408711 2.32707741194992 7.77692669177197e-05 mirMAP -0.758988325914963 5.91278512140696e-06 NA NA NA hsa-miR-26a-5p RAB6B -0.126411409001078 0.440028840408711 0.426395028584002 0.120299691474674 mirMAP -0.210769153379731 0.00691691758102342 NA NA NA hsa-miR-26a-5p REEP4 -0.126411409001078 0.440028840408711 0.315984168124229 0.0150083922804493 MirTarget;miRNATAP -0.183475745136519 5.15178842554797e-07 NA NA NA hsa-miR-26a-5p RFFL -0.126411409001078 0.440028840408711 0.426721617234353 0.000558496428099858 mirMAP -0.142103697458207 5.00973000372684e-05 NA NA NA hsa-miR-26a-5p RGS4 -0.126411409001078 0.440028840408711 0.196887922136346 0.564222419675049 MirTarget;miRNATAP -0.225061414925735 0.0204744481238227 NA NA NA hsa-miR-26a-5p RRM2 -0.126411409001078 0.440028840408711 2.86899871288903 2.94977476028636e-19 miRNAWalker2_validate -0.684477705219282 1.29123506933786e-13 NA NA NA hsa-miR-26a-5p RRP7A -0.126411409001078 0.440028840408711 0.375108963937195 0.0105734323893765 mirMAP -0.162901148752773 8.79399293597485e-05 NA NA NA hsa-miR-26a-5p SACS -0.126411409001078 0.440028840408711 0.271986545539879 0.121028594980551 MirTarget;miRNATAP -0.131333555590876 0.00838769741303311 NA NA NA hsa-miR-26a-5p SAMD8 -0.126411409001078 0.440028840408711 -0.201264705201723 0.177392008185443 MirTarget;miRNATAP -0.114516996296308 0.00681298944120092 NA NA NA hsa-miR-26a-5p SBNO1 -0.126411409001078 0.440028840408711 0.218633910021256 0.259585297783949 mirMAP;miRNATAP -0.199343874146769 0.000281149849187749 NA NA NA hsa-miR-26a-5p SENP5 -0.126411409001078 0.440028840408711 0.170944468360906 0.112988192741522 MirTarget;miRNATAP -0.125912018630905 3.36195796475594e-05 NA NA NA hsa-miR-26a-5p SERBP1 -0.126411409001078 0.440028840408711 0.232311646569641 0.0179938483001303 miRNAWalker2_validate;miRTarBase;MirTarget;mirMAP;miRNATAP -0.116042017432216 2.7012620210206e-05 27449037 Loss of miR 26a 5p promotes proliferation migration and invasion in prostate cancer through negatively regulating SERBP1; Using bioinformatics analysis we found that serpine1 messenger RNA mRNA binding protein 1 SERBP1 was a potential downstream target of miR-26a-5p; Using luciferase reporter and western blot we identified that miR-26a-5p negatively regulated SERBP1 on the PC cell line level; Additionally SERBP1 was identified as a downstream target of miR-26a-5p; Taken together our results for the first time demonstrate that the loss of miR-26a-5p promotes proliferation migration and invasion through targeting SERBP1 in PC supporting the tumor-suppressing role of miR-26a-5p in PC prostate cancer hsa-miR-26a-5p SFPQ -0.126411409001078 0.440028840408711 0.402743406767234 8.60211558041654e-06 MirTarget -0.100072491193864 9.74624230768174e-05 NA NA NA hsa-miR-26a-5p SFXN1 -0.126411409001078 0.440028840408711 1.44719603382287 8.17405309534878e-22 MirTarget -0.247194009724498 2.389590700727e-08 NA NA NA hsa-miR-26a-5p SH3BP2 -0.126411409001078 0.440028840408711 -0.177046443326433 0.196425689010702 mirMAP -0.127681612503964 0.000991678882738019 NA NA NA hsa-miR-26a-5p SKP2 -0.126411409001078 0.440028840408711 0.717491763754031 0.00193527376559042 MirTarget -0.344578615119354 1.32474185351954e-07 NA NA NA hsa-miR-26a-5p SLC39A14 -0.126411409001078 0.440028840408711 0.3112660848419 0.144979904125944 mirMAP -0.219435609421123 0.000285837039721376 NA NA NA hsa-miR-26a-5p SLC7A11 -0.126411409001078 0.440028840408711 2.66698751984437 1.54033004932319e-08 miRNATAP -0.454699758049495 0.000824827424589449 NA NA NA hsa-miR-26a-5p SPOCK1 -0.126411409001078 0.440028840408711 1.70903703280186 0.000671735079673281 mirMAP -0.525501285411029 0.000242736813580234 NA NA NA hsa-miR-26a-5p SRPK1 -0.126411409001078 0.440028840408711 1.47133479015789 2.65570317055346e-24 miRNATAP -0.169971099410312 7.97986675265026e-05 NA NA NA hsa-miR-26a-5p SSX2IP -0.126411409001078 0.440028840408711 0.506864070381275 0.0076135247073222 MirTarget;miRNATAP -0.225979399571408 2.65272505447359e-05 NA NA NA hsa-miR-26a-5p STMN1 -0.126411409001078 0.440028840408711 0.714015868848262 0.00218062135194851 miRNATAP -0.267772865897944 5.16652843135063e-05 NA NA NA hsa-miR-26a-5p SULF1 -0.126411409001078 0.440028840408711 1.69578952100777 1.25423223192775e-06 MirTarget;miRNATAP -0.377384084202654 0.000167280817947028 NA NA NA hsa-miR-26a-5p SUZ12 -0.126411409001078 0.440028840408711 0.492315482875409 9.57075781113426e-05 miRNATAP -0.146363122059953 4.40562986017982e-05 NA NA NA hsa-miR-26a-5p SYT7 -0.126411409001078 0.440028840408711 2.6105278424188 1.97386553274303e-10 mirMAP -0.329834718543743 0.00559727490651966 NA NA NA hsa-miR-26a-5p TAF5 -0.126411409001078 0.440028840408711 0.388278432661178 0.00227371322020449 miRNATAP -0.14468659362648 5.89688140308431e-05 NA NA NA hsa-miR-26a-5p TBC1D16 -0.126411409001078 0.440028840408711 0.345597272254261 0.0587525206050741 miRNAWalker2_validate -0.290604832138783 1.45507657488046e-08 NA NA NA hsa-miR-26a-5p TCP1 -0.126411409001078 0.440028840408711 0.222053980153833 0.069695601131034 miRNAWalker2_validate -0.142729274211598 3.55115251889761e-05 NA NA NA hsa-miR-26a-5p TET1 -0.126411409001078 0.440028840408711 1.15474049376582 1.6976203546407e-06 miRNATAP -0.21695744781067 0.00172651271554746 NA NA NA hsa-miR-26a-5p TFAP2A -0.126411409001078 0.440028840408711 3.63118958402229 8.17898472391641e-17 miRNATAP -0.383401464702457 0.00282032850472759 NA NA NA hsa-miR-26a-5p TKT -0.126411409001078 0.440028840408711 0.530383489348534 0.00301432204517301 miRNAWalker2_validate -0.173710476486243 0.000632387438433738 NA NA NA hsa-miR-26a-5p TMEM184B -0.126411409001078 0.440028840408711 0.0941766120464127 0.462380405521902 MirTarget;miRNATAP -0.182688768151767 3.67111462310608e-07 NA NA NA hsa-miR-26a-5p TMEM189 -0.126411409001078 0.440028840408711 0.175881223086224 0.177366297524708 MirTarget;miRNATAP -0.164637910237467 7.24019012793754e-06 NA NA NA hsa-miR-26a-5p TMEM38B -0.126411409001078 0.440028840408711 -0.0646912191448394 0.75952374328622 MirTarget -0.137570470537238 0.0219516516433609 NA NA NA hsa-miR-26a-5p TMTC3 -0.126411409001078 0.440028840408711 0.197015311797843 0.186747920068746 miRNATAP -0.172212131551869 4.32398067407306e-05 NA NA NA hsa-miR-26a-5p TNPO1 -0.126411409001078 0.440028840408711 0.251738379349596 0.0349260355369059 MirTarget -0.103749228005688 0.0021471777988389 NA NA NA hsa-miR-26a-5p TRAP1 -0.126411409001078 0.440028840408711 1.05008087041369 5.75590482780164e-16 miRNAWalker2_validate -0.171629335008955 5.47064507152997e-06 NA NA NA hsa-miR-26a-5p TRIM65 -0.126411409001078 0.440028840408711 0.399807075884659 0.00122017539272178 MirTarget -0.158276622075144 5.8662903162564e-06 NA NA NA hsa-miR-26a-5p TTPAL -0.126411409001078 0.440028840408711 0.628362943668103 3.85953011124262e-07 MirTarget -0.113741081759352 0.00133900683026378 NA NA NA hsa-miR-26a-5p TUBG1 -0.126411409001078 0.440028840408711 0.937443024309829 9.12437304120976e-10 miRNAWalker2_validate -0.394377428357969 1.54567915423733e-20 NA NA NA hsa-miR-26a-5p TWF1 -0.126411409001078 0.440028840408711 0.836013190055379 3.51260651137057e-08 MirTarget;miRNATAP -0.139366258792442 0.00139205527084307 NA NA NA hsa-miR-26a-5p UBA2 -0.126411409001078 0.440028840408711 0.288968307581134 0.0302353836489378 miRNAWalker2_validate -0.130864671991132 0.000528386195515407 NA NA NA hsa-miR-26a-5p UBE2H -0.126411409001078 0.440028840408711 0.456291647030759 0.000501298883563147 MirTarget;miRNATAP -0.133790107009631 0.00032857731610634 NA NA NA hsa-miR-26a-5p UBE2V2 -0.126411409001078 0.440028840408711 0.556674060608279 0.000112013341561722 mirMAP -0.192815746679638 2.32280871501292e-06 NA NA NA hsa-miR-26a-5p UBTF -0.126411409001078 0.440028840408711 0.185623331154604 0.0144628644698491 miRNAWalker2_validate;miRNATAP -0.119121373016874 1.68187459282983e-08 NA NA NA hsa-miR-26a-5p UBXN7 -0.126411409001078 0.440028840408711 0.0476095815672188 0.794620771591598 mirMAP -0.120285807258546 0.0205458284923217 NA NA NA hsa-miR-26a-5p UGGT1 -0.126411409001078 0.440028840408711 0.51003740287431 0.000134136989865437 MirTarget -0.14006192400646 0.000226778687422962 NA NA NA hsa-miR-26a-5p UHRF1BP1 -0.126411409001078 0.440028840408711 0.363185114425452 0.00984039826106316 MirTarget -0.126024167763497 0.00160216238316587 NA NA NA hsa-miR-26a-5p ULK1 -0.126411409001078 0.440028840408711 0.616445128058068 4.11216950040876e-05 miRNATAP -0.295199126819406 2.16699649045898e-12 NA NA NA hsa-miR-26a-5p UNC13A -0.126411409001078 0.440028840408711 0.611637394494186 0.157159453486073 mirMAP -0.252099382986489 0.0406807760168422 NA NA NA hsa-miR-26a-5p USP31 -0.126411409001078 0.440028840408711 -0.0028555707633533 0.984048217755574 mirMAP -0.176903305876641 1.07914971162245e-05 NA NA NA hsa-miR-26a-5p VANGL1 -0.126411409001078 0.440028840408711 0.482522450244504 0.00121744978200244 mirMAP -0.163660052828943 0.000110599784973222 NA NA NA hsa-miR-26a-5p VAPB -0.126411409001078 0.440028840408711 0.0615581473842584 0.602763031760505 mirMAP -0.109288659069746 0.00106779548950657 NA NA NA hsa-miR-26a-5p VDAC1 -0.126411409001078 0.440028840408711 0.566826279402601 2.22979244082283e-05 miRNATAP -0.116903554293692 0.00219456141453893 NA NA NA hsa-miR-26a-5p XPOT -0.126411409001078 0.440028840408711 0.842277783138104 5.54099502941227e-07 mirMAP -0.20902849890403 1.35685330673363e-05 NA NA NA hsa-miR-26a-5p YES1 -0.126411409001078 0.440028840408711 0.0716555082187087 0.625670821706797 miRNATAP -0.150717787846919 0.00028074451344835 NA NA NA hsa-miR-26a-5p ZNF286A -0.126411409001078 0.440028840408711 0.321534155603346 0.0402725661282039 mirMAP -0.155729447556689 0.000454829034376199 NA NA NA hsa-miR-26a-5p ZNF598 -0.126411409001078 0.440028840408711 0.734104266054326 7.51854095325325e-07 MirTarget -0.267711225906071 1.57290665186045e-10 NA NA NA hsa-miR-26a-5p ZNF623 -0.126411409001078 0.440028840408711 0.598799723685322 4.202262729275e-05 mirMAP -0.123648869782966 0.00306661867712119 NA NA NA hsa-miR-26a-5p ZNF697 -0.126411409001078 0.440028840408711 0.0296257625014902 0.86856215591802 miRNATAP -0.154415235875622 0.00233180978519324 NA NA NA hsa-miR-26a-5p ZNF813 -0.126411409001078 0.440028840408711 -0.026418906386003 0.897273131364056 mirMAP -0.125057082318341 0.0315036402735522 NA NA NA